Integer Holdings
ITGR
Market cap $4.78B

142.63 USD

-0.53

0.37%

Updated Jan 22, 10:52 AM EST

1 day

-0.37%

5 days

0.84%

1 month

6.70%

3 months

13.60%

6 months

10.41%

Year to date

7.91%

1 year

37.53%

5 years

56.63%

10 years

190.49%

About: Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.

Employees: 10,500

Healthcare Electromedical & Electrotherapeutic Apparatus

0

Funds holding %

of 6,823 funds

0

Analysts bullish %

of 5 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

86% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 28

68% more call options, than puts

Call options by funds: $1.77M | Put options by funds: $1.05M

12% more capital invested

Capital invested by funds: $4.57B [Q2] → $5.12B (+$544M) [Q3]

7% more funds holding

Funds holding: 311 [Q2] → 333 (+22) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

0.75% less ownership

Funds ownership: 118.09% [Q2] → 117.33% (-0.75%) [Q3]

4% less repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 115

See Fund Rankings

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$140

2%

downside

Avg. target

$150

5%

upside

High target

$163

14%

upside

5 analyst ratings

4 positive

80%

1 neutral

20%

0 negative

0%

Citigroup Joanne Wuensch 64% 1-year accuracy 30 / 47 met price target	2%upside $145	Neutral Maintained	11 Dec 2024
Truist Securities Richard Newitter 81% 1-year accuracy 34 / 42 met price target	14%upside $163	Buy Maintained	11 Dec 2024
Wells Fargo Nathan Treybeck 50% 1-year accuracy 2 / 4 met price target	12%upside $160	Overweight Reinstated	3 Dec 2024
Piper Sandler Matt O'Brien 59% 1-year accuracy 30 / 51 met price target	2%downside $140	Overweight Reiterated	25 Oct 2024
Benchmark Robert Wasserman 63% 1-year accuracy 31 / 49 met price target	2%downside $140	Buy Reiterated	25 Oct 2024

See Analyst Rankings

Financial journalist opinion

Based on 5 articles about ITGR published over the past 30 days

Zacks Investment Research

Integer (ITGR) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Integer (ITGR) is a Top-Ranked Value Stock: Should You Buy?

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

PLANO, Texas, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on January 1, 2025, and ending at the close of business on March 31, 2025. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company's common stock or a combination thereof, at the Company's election, in respect of the remainder, if any, of the Company's conversion obligation in excess of the aggregate principal amount of the Notes being converted. Any determination regarding the convertibility of the Notes during future periods will be made in accordance with the terms of the Indenture governing the Notes.

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

Zacks Investment Research

Here's Why You Should Retain Integer Holdings Stock in Your Portfolio

ITGR's research and product development activities raise optimism about the stock. Rising demand for its products bodes well for the company.

Here's Why You Should Retain Integer Holdings Stock in Your Portfolio

Zacks Investment Research

Integer Holdings Gains 34.4% in One Year: What's Driving the Stock?

ITGR shares gain on the back of growth in the Medical segment. However, dependence on third-party suppliers is concerning.

Integer Holdings Gains 34.4% in One Year: What's Driving the Stock?

Zacks Investment Research

Here's Why Integer (ITGR) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Integer (ITGR) is a Strong Value Stock

Zacks Investment Research

Why Integer (ITGR) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Integer (ITGR) is a Top Value Stock for the Long-Term

Zacks Investment Research

Integer (ITGR) is a Top-Ranked Growth Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Integer (ITGR) is a Top-Ranked Growth Stock: Should You Buy?

Zacks Investment Research

Here's Why Integer (ITGR) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why Integer (ITGR) is a Strong Growth Stock

Integer to Present at Piper Sandler Healthcare Conference on Dec. 3, 2024

PLANO, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), will participate in the Piper Sandler 36th Annual Healthcare Conference, to be held Dec. 3 – 5 in New York City. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present Tuesday, Dec. 3, 2024, at 10:30 a.m. EST.

Integer to Present at Piper Sandler Healthcare Conference on Dec. 3, 2024

Zacks Investment Research

Integer Holdings Gains 40.8% YTD: What's Driving the Stock?

ITGR shares gain on the back of growth in the Medical segment. However, fluctuations in the oil and energy market are concerning.

Integer Holdings Gains 40.8% YTD: What's Driving the Stock?

See News Rankings

Charts implemented using Lightweight Charts™